← Leaderboards
Gerald V Denis
Boston University Medical Campus
$6,096,787
Attributed
$9,644,715
Total exposure
14
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2005–24$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$9,644,715 · 14
By mechanism
U01$5,857,453 · 2
R01$3,050,911 · 1
R03$324,000 · 2
R29$242,143 · 1
P41$116,069 · 7
R56$54,139 · 1
Top collaborators
- Julie R Palmer6 shared
- Andrew Emili5 shared
- Stefano Monti5 shared
- Senthil K Muthuswamy3 shared
Most similar at Boston University Medical Campus
Same institution · by research overlap
- Julie R Palmer$31,282,207
- Lynn Rosenberg$61,388,332
- Emily Elizabeth Hurstak$813,240
- Stefano Monti$4,870,283
- Veronica M Vieira$5,420,787
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsBasePublishingProteinsTumorInnovationObesityMalignant Breast NeoplasmAffectMetabolicBreastBreast Cancer CellNeoplastic CellWomanMetforminGenesBromodomainCohortInsightInflammationAdipose TissueAnimal ModelInflammatoryChronic
Grant awards (32)
Multiscale analysis of metabolic inflammation as a driver of breast cancer$440,153
U01 · FY2024 · CA · contact PI
Multiscale analysis of metabolic inflammation as a driver of breast cancer$549,519
U01 · FY2023 · CA · contact PI
Multiscale analysis of metabolic inflammation as a driver of breast cancer$662,592
U01 · FY2022 · CA · contact PI
Mechanisms of BET bromodomain metabolic reprogramming in triple negative breast cancer$607,228
R01 · FY2022 · CA · contact PI
Mechanisms of BET bromodomain metabolic reprogramming in triple negative breast cancer$619,610
R01 · FY2021 · CA · contact PI
Multiscale analysis of metabolic inflammation as a driver of breast cancer$560,974
U01 · FY2021 · CA · contact PI
Mechanisms of BET bromodomain metabolic reprogramming in triple negative breast cancer$639,256
R01 · FY2020 · CA · contact PI
Multiscale analysis of metabolic inflammation as a driver of breast cancer$593,459
U01 · FY2020 · CA · contact PI
Mechanisms of BET bromodomain metabolic reprogramming in triple negative breast cancer$624,971
R01 · FY2019 · CA · contact PI
Mechanisms of BET bromodomain metabolic reprogramming in triple negative breast cancer$559,846
R01 · FY2018 · CA · contact PI
Uncoupling obesity from breast cancer in African American women$650,118
U01 · FY2017 · CA · contact PI
Uncoupling obesity from breast cancer in African American women$565,165
U01 · FY2016 · CA · contact PI
Uncoupling obesity from breast cancer in African American women$615,920
U01 · FY2015 · CA · contact PI
Uncoupling obesity from breast cancer in African American women$25,000
U01 · FY2015 · CA · contact PI
Uncoupling obesity from breast cancer in African American women$588,563
U01 · FY2014 · CA · contact PI
Uncoupling obesity from breast cancer in African American women$605,990
U01 · FY2013 · CA · contact PI
Mechanisms of Brd2 immunoprotection from insulin resistance$54,139
R56 · FY2011 · DK · contact PI
BRD2-MULTIPROTEIN COMPLEXES IN MAMMALIAN CELL CYCLE TRANSCRIPTIONAL CONTROL$9,312
P41 · FY2010 · RR · contact PI
BRD2-MULTIPROTEIN COMPLEXES IN MAMMALIAN CELL CYCLE TRANSCRIPTIONAL CONTROL$9,492
P41 · FY2009 · RR · contact PI
Proteomic biomarkers for lymphoma$81,250
R03 · FY2008 · CA · contact PI
BRD2-MULTIPROTEIN COMPLEXES IN MAMMALIAN CELL CYCLE TRANSCRIPTIONAL CONTROL$5,837
P41 · FY2008 · RR · contact PI
Proteomic biomarkers for lymphoma$81,250
R03 · FY2007 · CA · contact PI
BRD2-MULTIPROTEIN COMPLEXES IN MAMMALIAN CELL CYCLE TRANSCRIPTIONAL CONTROL$9,696
P41 · FY2007 · RR · contact PI
BRD2-MULTIPROTEIN COMPLEXES IN MAMMALIAN CELL CYCLE TRANSCRIPTIONAL CONTROL$3,072
P41 · FY2006 · RR · contact PI
Biomarkers for lymphoma in a new transgenic mouse model$80,750
R03 · FY2005 · CA
BRD2-MULTIPROTEIN COMPLEXES IN MAMMALIAN CELL CYCLE TRANSCRIPTIONAL CONTROL$3,064
P41 · FY2005 · RR
Biomarkers for lymphoma in a new transgenic mouse model$80,750
R03 · FY2004 · CA
BRD2-MULTIPROTEIN COMPLEXES IN MAMMALIAN CELL CYCLE TRANSCRIPTIONAL CONTROL$7,113
P41 · FY2004 · RR
NOVEL, INDUCIBLE NUCLEAR KINASE LINKED TO LEUKEMIA$122,861
R29 · FY2001 · CA
NOVEL MITOGEN ACTIVATED NUCLEAR KINASE$53,566
P41 · FY2001 · RR
NOVEL, INDUCIBLE NUCLEAR KINASE LINKED TO LEUKEMIA$119,282
R29 · FY2000 · CA
NOVEL MITOGEN ACTIVATED NUCLEAR KINASE$14,917
P41 · FY2000 · RR